Department of Renal Medicine, Singapore General Hospital, Singapore.
Department of Renal Medicine, Singapore General Hospital, Singapore.
J Vasc Surg. 2020 Apr;71(4):1333-1339. doi: 10.1016/j.jvs.2019.07.056. Epub 2019 Sep 3.
This study aimed to report the outcomes of endovascular salvage of clotted arteriovenous (AV) accesses and to determine potential predictors of poor patency rates after thrombectomy.
Records of hemodialysis patients who underwent endovascular salvage of clotted AV access were reviewed retrospectively. Technical and clinical success rates, complication rates, and 3- and 6-month patency rates were determined. Multivariate analysis was performed to determine the predictors of patency after thrombectomy.
A total of 294 patients underwent endovascular salvage of clotted AV access during the study period; 156 patients had arteriovenous fistula, whereas the remaining 138 were arteriovenous grafts (AVGs). The technical and clinical success rates were 96.3% and 93.2%; the major and minor complication rates were 0.7% and 9.9%. Post-thrombectomy primary, assisted primary, and secondary patency rates were 62.9%, 76.2%, and 77.6% at 3 months and 43.9%, 59.5%, and 61.6% at 6 months. The patency rates were significantly better for arteriovenous fistula than for AVG except for 6-month assisted primary and secondary patency. Multivariate Cox regression analysis showed that prior thrombosis within 90 days was significantly associated with loss of primary patency (hazard ratio [HR], 1.90; 95% confidence interval [CI], 1.21-2.98; P < .01), assisted primary patency (HR, 2.42; 95% CI, 1.42-4.13; P < .01), and secondary patency (HR, 2.52; 95% CI, 1.40-4.53; P < .01). Having an AVG was also negatively associated with primary patency.
Most clotted AV accesses can be salvaged by endovascular technique. Recurrent thrombosis within 90 days is associated with poor short- and long-term patency even after successful endovascular reinterventions.
本研究旨在报告动静脉(AV)内瘘血栓形成后的血管腔内再通治疗结果,并确定血栓切除术后通畅率低的潜在预测因素。
回顾性分析接受血管腔内再通治疗的动静脉内瘘血栓形成患者的病历记录。确定技术和临床成功率、并发症发生率以及 3 个月和 6 个月的通畅率。采用多变量分析确定血栓切除术后通畅的预测因素。
研究期间共 294 例患者接受了动静脉内瘘血栓形成的血管腔内再通治疗;156 例为动静脉瘘,其余 138 例为动静脉移植物(AVG)。技术和临床成功率分别为 96.3%和 93.2%;主要和次要并发症发生率分别为 0.7%和 9.9%。血栓切除术后 3 个月的原发通畅率、辅助原发通畅率和继发通畅率分别为 62.9%、76.2%和 77.6%,6 个月时分别为 43.9%、59.5%和 61.6%。动静脉瘘的通畅率明显优于 AVG,除了 6 个月的辅助原发通畅率和继发通畅率外。多变量 Cox 回归分析显示,90 天内发生的先前血栓形成与原发性通畅率丧失(危险比[HR],1.90;95%置信区间[CI],1.21-2.98;P<.01)、辅助原发性通畅率(HR,2.42;95%CI,1.42-4.13;P<.01)和继发性通畅率(HR,2.52;95%CI,1.40-4.53;P<.01)显著相关。AVG 也与原发性通畅率呈负相关。
大多数动静脉内瘘血栓形成可通过血管腔内技术挽救。90 天内的复发性血栓形成与短期和长期通畅率差相关,即使在成功的血管内再介入治疗后也是如此。